(The Hill) – Novo Nordisk announced plans on Monday to build a $4.1 billion facility in North Carolina, as demand for its popular weight-loss drugs has only increased in recent months. The plant will be the Danish company’s second fill and finishing manufacturing facility in Clayton, N.C., and its fourth facility in the area overall. (Read More)